Home Crystal structure of (Z)-4-(((4-fluorophenyl)amino)(furan-2-yl)methylene)-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one
Article Open Access

Crystal structure of (Z)-4-(((4-fluorophenyl)amino)(furan-2-yl)methylene)-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one

  • Qiong Wu , Li Zhang , Jun-Jie Gao , Liu Yang , Heng-Qiang Zhang ORCID logo , Li-Li Fan and Ya-Zhai Zhang EMAIL logo
Published/Copyright: May 20, 2022

Abstract

C22H16FN3O2, triclinic, P 1 (no. 2), a = 8.7335(18) Å, b = 9.967(2) Å, c = 11.968(3) Å, α = 70.677(4)°, β = 86.259(4)°, γ = 65.759(4) Å, V = 893.4(3) Å3, Z = 2, R gt (F) = 0.0543, wR ref (F2) = 0.1677, T = 296(2) K.

CCDC no.: 2170694

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.32 × 0.26 × 0.20 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.10 mm−1
Diffractometer, scan mode: φ and ω
θmax, completeness: 25.0°, 98%
N(hkl)measured, N(hkl)unique, Rint: 4758, 3143, 0.022
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 2275
N(param)refined: 250
Programs: Bruker [1], SHELX [2], WinGX/ORTEP [3], PLATON [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
H3A 0.889 (3) 0.317 (3) 0.137 (2) 0.053 (8)*
F1 0.5745 (3) 0.2596 (4) 0.59296 (16) 0.1249 (9)
O1 0.9798 (2) 0.2247 (2) 0.01124 (14) 0.0605 (5)
O2 0.6355 (3) 0.7131 (2) 0.14741 (18) 0.0716 (6)
N1 0.9336 (3) 0.3865 (2) −0.18788 (16) 0.0467 (5)
N2 0.8553 (3) 0.5467 (2) −0.25126 (17) 0.0475 (5)
N3 0.8118 (3) 0.3974 (3) 0.15034 (17) 0.0505 (5)
C1 1.0287 (3) 0.2835 (3) −0.2487 (2) 0.0438 (6)
C2 1.0598 (4) 0.1262 (3) −0.2036 (2) 0.0576 (7)
H2 1.015731 0.087924 −0.133425 0.069*
C3 1.1558 (4) 0.0280 (3) −0.2631 (3) 0.0697 (8)
H3 1.178932 −0.077683 −0.231571 0.084*
C4 1.2186 (4) 0.0825 (4) −0.3685 (3) 0.0696 (8)
H4 1.282999 0.014638 −0.408175 0.083*
C5 1.1851 (4) 0.2384 (4) −0.4145 (2) 0.0640 (8)
H5 1.225724 0.276401 −0.486369 0.077*
C6 1.0916 (3) 0.3392 (3) −0.3550 (2) 0.0546 (7)
H6 1.070974 0.444399 −0.386264 0.065*
C7 0.9140 (3) 0.3552 (3) −0.0680 (2) 0.0466 (6)
C8 0.8038 (3) 0.5050 (3) −0.0569 (2) 0.0438 (6)
C9 0.7793 (3) 0.6159 (3) −0.1748 (2) 0.0443 (6)
C10 0.6910 (4) 0.7897 (3) −0.2175 (3) 0.0649 (8)
H10A 0.723473 0.831082 −0.295128 0.097*
H10B 0.721215 0.829515 −0.163622 0.097*
H10C 0.571362 0.820277 −0.221347 0.097*
C11 0.7452 (3) 0.5199 (3) 0.05040 (19) 0.0431 (6)
C12 0.6120 (3) 0.6629 (3) 0.0608 (2) 0.0467 (6)
C13 0.4582 (3) 0.7500 (4) 0.0036 (2) 0.0700 (9)
H13 0.411302 0.738354 −0.058262 0.084*
C14 0.3817 (4) 0.8674 (4) 0.0616 (4) 0.0921 (13)
H14 0.274449 0.948200 0.042782 0.111*
C15 0.4924 (6) 0.8374 (4) 0.1451 (3) 0.0940 (13)
H15 0.474505 0.894596 0.196074 0.113*
C16 0.7466 (3) 0.3692 (3) 0.2643 (2) 0.0468 (6)
C17 0.8574 (4) 0.2886 (3) 0.3641 (2) 0.0621 (7)
H17 0.972349 0.258713 0.356710 0.075*
C18 0.7990 (4) 0.2517 (4) 0.4755 (2) 0.0769 (9)
H18 0.873732 0.195886 0.543213 0.092*
C19 0.6313 (4) 0.2982 (4) 0.4838 (2) 0.0745 (9)
C20 0.5191 (4) 0.3784 (4) 0.3878 (3) 0.0782 (9)
H20 0.404314 0.409484 0.396599 0.094*
C21 0.5766 (4) 0.4136 (4) 0.2765 (2) 0.0642 (8)
H21 0.500464 0.467533 0.209442 0.077*

Source of material

All reagents were obtained from commercial sources and used without further purification. A mixture of a 10 mL HPMFP (2 mmol, 0.5366 g) anhydrous ethanol solution, and a 10 mL 4-fluoroaniline (2 mmol, 0.2221 g) anhydrous ethanol solution was refluxed for ca. 3 h, adding a few drops of glacial acetic acid as a catalyst. Then ethanol was removed by evaporation and the resulting yellow precipitate formed was filtered off, washed with cold anhydrous ethanol and dried in air. Yellow block crystals suitable for analysis were obtained by slowly evaporation of a solution in anhydrous ethanol at room temperature for a few days.

Experimental details

The structure was solved by direct methods with the SHELXS-2018 program [2]. The H atoms bonded to N3 atoms were located in difference maps and refined freely. Other H atoms were placed in calculated positions, with C–H = 0.93 for phenyl and furyl, 0.96 for methyl H atoms, and refined as riding, with Uiso(H) values of 1.2Ueq(C) for phenyl and furyl H and 1.5Ueq(C) for methyl H.

Comment

4-Acylpyrazolones are an interesting class of β-diketones, containing a pyrazole-bearing moiety. Thus, related metal complexes are used for the separation of elements with similar properties [5]. Some β-diketonate based compounds also have recently provoked a growing interest for various reasons [6], [7], [8]. Only a few studies have involved heterocyclic substituents at the 4-position. In recent years, we have reported the Schiff bases derived from 4-heterocyclic acylpyrazolones and their complexes, which possess high antibacterial activation [910]. Knowledge of the crystal structure of such acylpyrazolones derivatives gives us not only sufficient information about nuclearity of the complex, but is important for the understanding of the compounds in the vapour phase, and the mechanisms of sublimation and decomposition.

In the title crystal structure, the compound crystallized with a structural configuration in which the phenyl ring(C(1)–C(6)) is twisted with a dihedral angle of 23.73(15)° with respect to a plane defined by the pyrazole ring. The O1 atom of pyrazole ring and the O(1)/C(7)/C(8)/C(11)/N(3) plane are nearly coplanar with the largest deviation of 0.028 Å. The bond length of C(8)–C(11) (1.383(3) Å) between the usual C–C and C=C bonds indicates the delocalization of the electrons because of the addition of a proton to N(3) is more favourable than to O(1) in the Fourier map (keto-form). The atom O(1) of 1-phenyl-3-methyl-4-(furoyl)-pyrazolone-5 moiety and the N(3) atom of the 4-Fluoroaniline group are on the same side of C(8)–C(11) bond, which are available for coordination with metal cations. A strong intramolecular N(3)–H(3A)⃛O(1) hydrogen bond is observed, as part of the enamine-keto tautomerism. Two other weak intramolecular bonds C(6)–H(6)⃛O(2) and C(2)–H(2)⃛O(1) are also found, stabilizing the structure. All bond lengths and angles are normal and comparable with those found for related compounds [11], [12], [13].


Corresponding author: Ya-Zhai Zhang, Department of Chemistry, Hebei Normal University for Nationalities, Chengde 067000, P. R. China, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Foundation of Hebei Education Department (No. ZD2020412) and the Foundation of Health Commission of Hebei Province (No. 20201320).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. BRUKER. SAINT, APEX2 SADABS; Bruker AXS Inc., Madison, WI, 2008.Search in Google Scholar

2. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8. https://doi.org/10.1107/s2053229614024218.Search in Google Scholar

3. Farrugia, L. J. WinGX and Ortep for Windows: an update. J. Appl. Crystallogr. 2012, 45, 849–854. https://doi.org/10.1107/s0021889812029111.Search in Google Scholar

4. Spek, A. L. Structure validation in chemical crystallography. Acta Crystallogr. 2009, D65, 148–155. https://doi.org/10.1107/s090744490804362x.Search in Google Scholar

5. Nishihama, S., Hirai, T., Komasawa, I. Review of advanced liquid-liquid extraction systems for the separation of metal ions by a combination of conversion of the metal species with chemical reaction. Ind. Eng. Chem. Res. 2001, 40, 3085–3091. https://doi.org/10.1021/ie010022+.10.1021/ie010022+Search in Google Scholar

6. Rahman, M., Siddiqui, A. Pyrazoline derivatives: a worthy insight into the recent advances and potential pharmacological activities. Int. J. Pharmaceut. Sci. Drug Res. 2010, 2, 165–175.10.4172/2150-3494.1000021Search in Google Scholar

7. Marchetti, F., Pettinari, C., Pettinari, R. Acylpyrazolone ligands: synthesis, structures, metal coordination chemistry and applications. Coord. Chem. Rev. 2005, 249, 2909–2945. https://doi.org/10.1016/j.ccr.2005.03.013.Search in Google Scholar

8. Mukherjee, R. Coordination chemistry with pyrazole-based chelating ligands: molecular structural aspects. Coord. Chem. Rev. 2000, 203, 151–158. https://doi.org/10.1016/s0010-8545(99)00144-7.Search in Google Scholar

9. Zhang, H.-Q., Li, J.-Z., Zhang, Y., Zhang, D. Synthesis, crystal structure and thermal stability of a one-dimensional chain acylpyrazolone complex Zn(C26H15N3O2Cl)2. Chin. J. Inorg. Chem. 2008, 24, 990–993.Search in Google Scholar

10. Li, J.-Z., Li, Y. G., Yu, W.-J. Synthesis, characterization and bioactivity of complexes of rare earth with bis-Schiff base from furoylpyrazolone. J. Rare Earths 2000, 18, 233–236.Search in Google Scholar

11. Zhang, H.-Q., Yang, X., Wu, Q., Chen, H.-L. Crystal structure of (4Z)- 4-{[(2-chlorophenyl)amino](furan-2-yl)methylidene}-3-methyl-1-phenyl -4,5-dihydro-1H-pyrazol-5-one. Acta Crystallogr. 2015, E71, o177–o178. https://doi.org/10.1107/s2056989015002698.Search in Google Scholar PubMed PubMed Central

12. Zhang, H.-Q., Wu, Q., Jin, T.-Y., Li, Y.-Y., Chen, H.-L. Crystal structure of (Z)-2-(4-chlorophenyl)-4-(furan-2-yl(phenylamino)methylene)-5-methyl -2,4-dihydro-3H-pyrazol-3-one, C21H16ClN3O2. Z. Kristallogr. N. Cryst. Struct. 2018, 233, 883–884. https://doi.org/10.1515/ncrs-2018-0075.Search in Google Scholar

13. Zhang, B.-Q., Zhang, L., Zhang, H.-Q., Zhao, C.-L., Chen, B. Crystal structure of (Z)-4-(furan-2-yl(p-tolylamino)methylene)-3-methyl-1-p- tolyl-1H-pyrazol-5(4H)-one, C23H21N3O2. Z. Kristallogr. N. Cryst. Struct. 2016, 231, 281–283. https://doi.org/10.1515/ncrs-2015-0120.Search in Google Scholar

Received: 2022-04-05
Accepted: 2022-05-05
Published Online: 2022-05-20
Published in Print: 2022-08-26

© 2022 Qiong Wu et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of N-((3s,5s,7s)-adamantan-1-yl)-2-(3-benzoylphenyl)propanamide, C26H29NO2
  4. The crystal structure of bis(μ2-5-chloro-2-oxido-N-(1-oxidopropylidene)benzohydrazonato-κ5 N,O,O′:N′,O′′)-octakis(pyridine-κ1 N)trinickel(II) C60H56Cl2N12Ni3O6
  5. The crystal structure of 3-(4-chlorophenyl)-1,5-di-p-tolylpentane-1,5-dione, C25H23ClO2
  6. The crystal structure of 2,4,4-triphenyl-4H-benzo[b][1,4]oxaphosphinin-4-ium bromide – dichloromethane (1/1), C27H22BrCl2OP
  7. The crystal structure of 2-(3,6-di-tert-butyl-1,8-diiodo-9H-carbazol-9-yl)acetonitrile, C22H24I2N2
  8. Crystal structure of 3-phenylpropyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H24O3
  9. The crystal structure of (4-fluorophenyl)(5-(hydroxymethyl)furan-2-yl)methanol, C12H11FO3
  10. Crystal structure of the dihydrate of tetraethylammonium 1,3,5-thiadiazole-5-amido-2-carbamate, C11H27N5O4S
  11. Crystal structure of (Z)-4-[(p-tolylamino)(furan-2-yl)methylene]-3-phenyl-1-1-p-tolyl-1H-phenyl-1H-pyrazol-5(4H)-one, C28H23N3O2
  12. The crystal structure of (E)-3-(2-chlorophenyl)-1-ferrocenylprop-2-en-1-one, C19H15ClFeO
  13. The pseudosymmetric crystal structure of 3-((1R,2S)-1-methylpyrrolidin-1-ium-2-yl)pyridin-1-ium hexachloridostannate(IV), C10H16N2SnCl6
  14. Crystal structure of (2-(1-hydroxyheptyl)octahydro-8aH-chromene-5,8,8a-triol), C16H30O5
  15. The crystal structure of N-cyclohexyl-3-hydroxy-4-methoxybenzamide, C14H19NO3
  16. Crystal structure of 1-(4-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene-2,7-diol from Arundina graminifolia, C22H20O4
  17. The crystal structure of N-cyclopentyl-3-hydroxy-4-methoxybenzamide, C13H17NO3
  18. The crystal structure of 2,5,5-triphenyl-3,5-dihydro-4H-imidazol-4-one, C21H16N2O
  19. Crystal structure of 1H-1,2,3-Triazolo[4,5-b]-pyridin-4-ium nitrate, C5H5N5O3
  20. Crystal structure of (Z)-4-(((4-bromophenyl)amino)(furan-2-yl)methylene)-2,5-diphenyl-2,4-dihydro-3H-pyrazol-3-one, C26H18BrN3O2
  21. Crystal structure of 2-(4-methoxyphenyl)-3-methyl-1,8-naphthyridine, C16H14N2O
  22. The crystal structure of 3-([1,1′-biphenyl]-2-yl)-1,2-diphenylbenzo[b]phosphole-1-oxide, C32H23OP
  23. The crystal structure of ammonium (E)-4-((4-carboxyphenyl)diazenyl)benzoate, C14H13N3O4
  24. Crystal structure of bis(5-amino-1,2,4-triazol-4-ium-3-yl)methane sulfate, C5H10N8O4S
  25. The crystal structure of phenantroline-κ2 N,N′-bis(6-phenylpyridine-2-carboxylato-κ2 N,O)copper(II), C36H24N4O4Cu
  26. The crystal structure of tris(6-methylpyridin-2-yl)phosphine oxide, C18H18N3OP
  27. The crystal structure of N-(2′-hydroxymethyl-5′-phenyl-3′,4′-dihydro-[1,1′:3′,1″-terphenyl]- 1′(2′H)-yl)-P,P-diphenylphosphinic amide, C37H34NO2P
  28. Crystal structure of (E)-4-(6-(4-(2-(pyridin-4-yl)vinyl)phenoxy)pyrimidin-4-yl)morpholine, C21H20N4O2
  29. Crystal structure of 5-(adamantan-1-yl)-3-[(4-trifluoromethylanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione, C20H22F3N3OS
  30. Crystal structure of 2,2-dichloro-1-(4-chloro-1H-indol-1-yl)ethan-1-one, C10H6Cl3NO
  31. The crystal structure of 4-(((3-bromo-5-(trifluoromethyl)pyridin-2-yl)oxy)methyl)benzonitrile, C28H16Br2F6N4O2
  32. The crystal structure of 1H-benzimidazole-2-carboxamide, C8H7N3O
  33. The crystal structure of Histidinium hydrogensquarate, C10H11N3O6
  34. The crystal structure of 3-amino-5-carboxypyridin-1-ium iodide, C6H7IN2O2
  35. Crystal structure of (E)-amino(2-(3-ethoxy-4-hydroxybenzylidene)hydrazineyl)methaniminium nitrate hemihydrate C10H16N5O5.5
  36. Crystal structure of 1,2-bis(4,5-dinitro-1H-imidazol-1-yl)ethane, C8H6N8O8
  37. The crystal structure of diaqua-bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2N,O)manganese(II), C14H12N6O6Mn
  38. The crystal structure of catena-poly[aqua-2,2′bipyridine-κ2N,N′-(μ2-5-ethoxyisophthalato-κ 4O,O:Oʺ,O′ʺ)cadmium(II)] monohydrate, C20H20CdN2O7
  39. The crystal structure of (1S,3R)-1-(4-isopropylphenyl)-3-(methoxycarbonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-iumchloride monohydrate, C22H27ClN2O3
  40. Crystal structure of 1-isopropyl-3-(prop-1-en-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, C11H15N5
  41. The crystal structure of (2,2′-bipyridine-κ2N,N′)- bis(6-phenylpyridine-2-carboxylate-κ2N,O)manganese(II)] monohydrate, C34H26N4O5Mn
  42. Crystal structure of the cocrystal 1,3,5,7-tetranitro-1,3,5,7-tetrazoctane ─ 2,3-dihydroindole (1/1), C12H17N9O8
  43. Crystal structure of 3-acetyl-6-hydroxy-2H-chromen-2-one monohydrate, C11H10O5
  44. Crystal structure of 6,9-diamino-2-ethoxyacridinium 3,5-dinitrobenozate — dimethylsulfoxide — water (1/1/1), C24H27N5O9S
  45. The crystal structure of 4,4′-bipyridinium bis-(2-hydroxy-3-methoxybenzoate), 2(C8H7.68O4)·C10H8.64N2
  46. Crystal structure of (Z)-4-(((4-fluorophenyl)amino)(furan-2-yl)methylene)-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one
  47. The crystal structure of bis(4-chloro-2-(((2-chloroethyl)imino)methyl)phenolato-κ2N,O)-oxidovanadium(IV), C18H16Cl4N2O3V
  48. The crystal structure of 17-(bromoethynyl)-17-hydroxy-10, 13-dimethyl- 1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C21H27BrO2
  49. The crystal structure of 4-((6-fluoropyridin-2-yloxy)methyl)benzonitrile, C13H9FN2O
  50. Crystal structure of (Z)-2-(1-bromo-2-phenylvinyl)-5-ethyl-2-methyl-1,3-dioxane-5-carboxylic acid, C15H17Br1O4
  51. Crystal structure of catena-poly[tribenzyl-κ1C-(μ2-6-oxidopyridin-1-ium-3-carboxylato-κ2O:O’)tin(IV)-dichloromethane-methanol (1/1/1), C29H31Cl2NO4Sn
  52. Crystal structure of bis{2-(tert-butyl)-6-((E)-((4-((E)-1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}zinc(II), C40H46N4O4Zn
  53. Crystal structure of diaqua-bis(μ2-2-carboxy-3,4,5,6-tetrafluorobenzoato-κ2O:O′)-bis(phenanthroline-κ2N,N′)-bis(μ2-3,4,5,6-tetrafluorophthalato-κ3O:O,O′)dieuropium(III) – phenanthroline (1/2), C40H19EuF8N4O9
  54. The crystal structure of diaqua-bis(6-phenylpyridine-2-carboxylato-κ2N,O) manganese(II) — water — dimethylformamide (1/2/1), C27H31N3O9Mn
  55. The crystal structure of bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2N,O)-copper(ii), C14H8N6O4Cu
  56. Crystal structure of poly[(μ2-1-(1-imidazolyl)-4-(imidazol-1-ylmethyl)benzene-κ2N:N′)-(μ3-pyridazine-4,5-dicarboxylate-κ3O:O′:N)]copper(II) hydrate, C19H16CuN6O5
  57. Crystal structure of acrinidinium tetrafluorohydrogenphthalate, C21H11F4NO4
  58. Crystal structure of 2-(1H-pyrazol-3-yl-κN)pyridine-κN-bis(2-(2,4-difluorophenyl)pyridinato-κ2C,N)iridium(III) sesquihydrate, C30H18F4IrN5·1.5[H2O]
  59. Crystal structure of 2-(2-hydroxy-5-nitrophenyl)-5-methyl-1,3-dioxane-5-carboxylic acid, C12H13N1O7
  60. The crystal structure of 1,2-bis(pyridinium-4-yl)ethane diperchlorate, C12H14N2·2ClO4 – a second polymorph
  61. The crystal structure of [(1,10-phenantroline-κ2N,N′)-bis(6-phenylpyridine-2-carboxylato-κ2N,O)manganese(II)] monohydrate, C36H26N4O5Mn
  62. Crystal structure of 1,2-bis(2,2,3,3,5,5,5-heptamethyl-1,1,4,4- tetrakis(trimethylsilyl)pentasilan-1-yl)ditellane, C38H114Si18Te2
  63. Crystal structure of 1,2-bis(2,4-dinitro-1H-imidazol-1-yl)ethane – dimethylformamide (1/1), C11H13N9O9
  64. Crystal structure of (Z)-3-((tert-butylamino) methylene)-2-(2-hydroxynaphthalen-1-yl) chroman-4-one, C24H23NO3
  65. Synthesis and crystal structure of (E)-1-(4-(((E)-3-(tert-butyl)-2-hydroxybenzylidene)amino)phenyl)ethan-1-one O-ethyl oxime, C21H26N2O2
  66. Crystal structure of the double salt bis(5-amino-1,2,4-triazol-4-ium-3-yl)methane hydrogen oxalate hemioxalate, C8H11N8O6
  67. Hydrothermal synthesis and crystal structure of catena-poly[diaqua-bis(μ2-4-[(4-pyridinylmethyl)amino]benzoato-κ2N:O)cobalt(II)]–1,2bi(4-pyridyl)ethene–water (1/1/1), C50H50N8O8Co
  68. Crystal structure of 3-(3-bromophenyl)-1′,3′-dimethyl-2′H,3H,4H-spiro[furo[3, 2-c]chromene-2,5′-pyrimidine]-2′,4,4′,6′(1′H,3′H) tetraone, C22H15BrN2O6
  69. The crystal structure of poly[aqua-(μ2-4,4′- bis(imidazolyl)biphenyl-κ2N:N′)-(μ2-3-nitrobenzene-1,2-dicarboxylato-κ2O:O′)]copper (II) hydrate, C26H21N5O8Cu
  70. The crystal structure of bis(4-(6-carboxy-8-ethyl-3-fluoro-5-oxo-5,8-dihydro-1,8-naphthyridin-2- yl)piperazin-1-ium) adipate tetrahydrate, C36H52F2N8O14
  71. Synthesis and crystal structure of poly[aqua(μ4-(1R,2S,4R)-4-hydroxy-1-((7-hydroxy-3-(4-hydroxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)pyrrolidin-1-ium-2-carboxylate-κ4O:O′:O″:O‴)sodium(I)] monohydrate, C21H22NNaO12S
  72. Crystal structure of chlorido-(η6-toluene)(2,2′-bipyridine-κ2N,N′)ruthenium(II) hexafluorophosphate, C17H16ClN2RuPF6
  73. The crystal structure of (R)-6-hydroxy-8-methoxy-3-methylisochroman-1-one, C11H12O4
  74. Crystal structure of catena-poly[(5,5,7,12,12,14-hexamethyl -1,4,8,11-tetraazacyclotetradecane- κ4N,N′,Nʺ,N‴)nickel(II)-(μ2-perchlorato-κ2O:O′)] 3,5-dicarboxybenzoate – methanol (1/2), C27H49ClN4NiO12
  75. The crystal structure of 4-(chloromethyl)benzonitrile, C8H6ClN
  76. The crystal structure of dimethylammonium 8-[(7,9-dioxo-6,10-dioxaspiro[4.5]decan-8-ylidene)methyl]-9-oxo-6,10-dioxaspiro[4.5]dec-7-en-7-olate, C19H25NO8
  77. Crystal structure of (2R,3S,4S,5R,6S)-2-(acetoxymethyl)-6-((1-acetyl-5-bromo-4-chloro-1H-indol-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate hemihydrate C24H25BrClNO11
  78. The crystal structure of the co-crystal tetrakis[2-(tris(4-methoxyphenyl)stannyl)ethyl]silane – tetrahydrofuran – toluene – tetrahydrofurane (1/1/1), C103H116O13SiSn4
  79. Crystal structure of methyl 3-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propanoate, C16H13NO4
  80. Crystal structure of ethyl (Z)-3-amino-2-cyano-3-(2-oxo-2H-chromen-3-yl)acrylate, C15H12N2O4
  81. Crystal structure of methyl 2-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetate, C15H11NO4
  82. Crystal structure of catena-poly[diaqua-bis(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)cobalt(II)] tetrafluoroterephthalate, C26H28N8O6F4Co
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2022-0173/html
Scroll to top button